Digital Nutrition Therapy for Patients With IBD

NAUnknownINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

October 15, 2022

Conditions
Crohn DiseaseUlcerative Colitis
Interventions
OTHER

LYFE MD app

"LyfeMD app is a digital health platform for patients living with both Crohn's disease (CD) and Ulcerative colitis (UC). LyfeMD is meant to help people live and thrive while managing their inflammatory disease with holistic, easy-to-implement, evidence based lifestyle therapies. LyfeMD is one app with multiple features - ranging from customized diet using anti-inflammatory principles identified from recent research, exercise plans to mindfulness and stress reduction programs. It helps patients make therapeutic diet choices to treat inflammation and provides stress reduction strategies when they feel unwell. The LyfeMD app also supports patients to maintain remission even when they're feeling well with trusted resources designed to keep them symptom free.~In addition to delivering personalized and interactive support, the app uses behaviour science to help patients change their habits, improve their health and reduce the burden IBD places on their lives."

Trial Locations (1)

T2N 4Z6

RECRUITING

TRW building, Foothills, University of Calgary, Calgary

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Calgary

OTHER

NCT04653259 - Digital Nutrition Therapy for Patients With IBD | Biotech Hunter | Biotech Hunter